SATYEN MADKAIKER: Open Payments
NPI 1588629232 · JACKSONVILLE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,101 in 82 payments from 15 companies in 2025. Trend: 2023 $1,881 · 2024 $1,947 · 2025 $2,101
Food & beverage: $2,101
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $469 |
| Axsome Therapeutics, Inc. | 11 | $344 |
| E.R. Squibb & Sons, L.L.C. | 8 | $240 |
| Otsuka America Pharmaceutical, Inc. | 13 | $230 |
| ABBVIE INC. | 14 | $212 |
| Vanda Pharmaceuticals Inc. | 6 | $190 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $106 |
| Neurocrine BioSciences, Inc. | 4 | $98 |
| Alkermes, Inc. | 4 | $95 |
| Bausch Health US, LLC | 2 | $41 |
Products named: CAPLYTA, Auvelity, COBENFY, VRAYLAR, FANAPT, ABILIFY ASIMTUFII, REXULTI, TRINTELLIX.
Industry payments across FL — which companies pay providers there.
